Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
placeholder image: silhouette of female physician

Rachel C Jankowitz, MD Physician

Director, Rena Rowan Breast Center Associate Professor of Clinical Medicine

Dr. Jankowitz is employed by Penn Medicine.

Call 800-789-7366 Request a Callback
No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.
X

Clinical Specialties

Specialty:

  • Medical Oncology

Programs & Centers:

Board Certification:

  • Medical Oncology, 2009

Clinical Expertise:

  • Adjuvant Chemotherapy
  • Aromatase Inhibitor
  • Atypical Ductal Hyperplasia
  • BRCA
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer During Pregnancy
  • Breast Cancer Follow Up
  • Breast Cancer Genetics
  • Breast Cancer High-Risk Counseling
  • Carcinoma In Situ of Breast
  • Cystosarcoma Phyllodes
  • ER Negative Breast Cancer
  • ER Positive Breast Cancer
  • Family History of Breast Cancer
  • Herceptin
  • Hereditary Breast and Ovarian Cancer
  • Immunotherapy
  • Inflammatory Breast Cancer (IBC)
  • Invasive Breast Cancer
  • Lobular Neoplasia
  • Male Breast Cancer
  • Neoadjuvant Chemotherapy
  • Sentinel Lymph Node Biopsy
  • Tamoxifen
  • Triple-Negative Breast Cancer
Show All Expertise

Practice Locations and Appointments

  • Rena Rowan Breast Center

    Abramson Cancer Center Perelman Center for Advanced Medicine, West Pavilion, 3rd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-7366 (PENN)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Temple University School of Medicine
Residency: University of Pittsburgh Medical Center
Fellowship: University of Pittsburgh Medical Center

Memberships

American Society of Clinical Oncology, National Lobular Breast Cancer Alliance, National National Surgical Adjuvant Bowel and Breast Project, National Translational Breast Cancer Research Consortium, National

Hospital Affiliation

Dr. Jankowitz is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Mohamed AA, Luo Y, Peng H, Jankowitz RC, Wu S.: Understanding Clinical Mammographic Breast Density Assessment: a Deep Learning Perspective. J Digit Imaging. 31 (4): 387-392,2018.

Landmann A, Farrugia DJ, Zhu L, Diego EJ, Johnson RR, Soran A, Dabbs DJ, Clark BZ, Puhalla SL, Jankowitz RC, Brufsky AM, Ahrendt GM, McAuliffe PF, Bhargava R.: Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease? Am J Clin Pathol 150 (1): 34-42,2018.

Clark BZ, Farrugia DJ, Landmann A, Diego EJ, Dabbs DJ, Puhalla SL, Jankowitz RC, Brufsky AM, Ahrendt GM, McAuliffe PF, Bhargava R.: Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer. Am J Clin Pathol. 149 (4): 332-43,2018.

Mohamed AA, Berg WA, Peng H, Luo Y, Jankowitz RC, Wu S.: A deep learning method for classifying mammographic breast density categories. Med Phys. 45 (1): 314-321,2018.

Gordon PB, Berg WA, Jankowitz RC.: Breast Cancer Recurrence after Initial Detection with Screening US Radiology 285 (33): 1054-55,2017.

Farrugia DJ, Landmann A, Zhu L, Diego EJ, Johnson RR, Bonaventura M, Soran A, Dabbs DJ, Clark BZ, Puhalla SL, Jankowitz RC, Brufsky AM, Lembersky BC, Ahrendt GM, McAuliffe PF, Bhargava R.: Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors. Mod Pathol. 30 (8): 1078-1085,2017.

Matthew A, Rajagopal PS, Villgran V, Sandhu GS, Jankowitz RC, Jacob M, Rosenzweig M, Oesterreich S, Brufsky A.: Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast. Geburtshilfe Frauenheilkd. 77 (6): 660-666,2017.

Connolly RM, Li H, Jankowitz RC, Zhang Z, Rudek MA, Jeter SC, Slater SA, Powers P, Wolff AC, Fetting JH, Brufsky A, Piekarz R, Ahuja N, Laird PW, Shen H, Weisenberger DJ, Cope L, Herman JG, Somlo G, Garcia AA, Jones PA, Baylin SB, Davidson NE, Zahnow CA, Stearns V.: Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study. Clin Cancer Res. 23 (11): 2691-2701,2017.

Wu S, Zuley ML, Berg WA, Kurland BF, Jankowitz RC, Sumkin JH, Gur D.: DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post contrast Sequence: Association with Breast Cancer Presence. Sci Rep. 7 (1): 2115,2017.

Jankowitz RC, Levine K, Zamanian M, Sikora M, Tasdemir N, McAuliffe P, Dabbs D, Davidson N, Diergaarde B, Oesterreich S.: Associations between biomarkers and outcome in a patient cohort with invasive lobular carcinoma. American Association of Cancer Research Annual Meeting, Washington, DC : 2017.

Academic Contact Info

Magee-Women's Hospital
300 Halket Street, Room 3524

Pittsburgh , PA 15213
Patient appointments: 800-789-7366 (PENN)